Varian Medical Systems (VAR) Reports In-Line Q2 EPS, Revenues Beat; Withdraws FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Varian Reports Results for Second Quarter of Fiscal Year 2020; Withdraws 2020 Guidance
May 4, 2020 4:15 PM EDTPALO ALTO, Calif., May 4, 2020 /PRNewswire/ --Â
Second Quarter 2020 Summary
Oncology Systems gross orders grew 1% in dollars or 2% in constant currency in the quarter; trailing twelve months gross orders grew 5% in dollars or 6% in constant currency 15 EthosTM orders received, including 11 in North America, 3 in Europe and 1 in Asia-Pacific Two Proton orders awarded in Asia-Pacific Total company revenues grew 2% in dollars, or 3% in constant currency, to $794 million; organic revenues declined 1%(1) GAAP operating earnings declined 50% at 6.9% of revenues; non-GAAP operating earnings declined 14% at 12.9% of revenues GAAP net... More